# Steric Interference of Adhesion Supports In-Vitro Chondrogenesis of Mesenchymal Stem Cells on Hydrogels for Cartilage Repair

**Authors:** Revital Goldshmid, Shlomit Cohen, Yonatan Shachaf, Ilana Kupershmit, Offra Sarig-Nadir, Dror Seliktar, Roni Wechsler

PMC · DOI: 10.1038/srep12607 · Scientific Reports · 2015-09-28

## TL;DR

This study shows that modifying fibrinogen with PEG improves cartilage formation by human stem cells in lab conditions, offering a better material for cartilage repair.

## Contribution

The study introduces a PEG-modified fibrinogen hydrogel that enhances chondrogenesis while minimizing hypertrophy in BM-MSCs.

## Key findings

- PEG-fibrinogen substrates supported chondrogenic markers like collagen II and aggrecan, unlike natural fibrin.
- Steric interference and increased stiffness of PEG-fibrinogen likely promote a chondrogenic phenotype in BM-MSCs.
- GelrinC™, a PF composition, was optimal for chondrogenic differentiation while reducing collagen X expression.

## Abstract

Recent studies suggest the presence of cell adhesion motifs found in structural proteins can inhibit chondrogenesis. In this context, the current study aims to determine if a polyethylene glycol (PEG)-modified fibrinogen matrix could support better chondrogenesis of human bone marrow mesenchymal stem cells (BM-MSC) based on steric interference of adhesion, when compared to a natural fibrin matrix. Hydrogels used as substrates for two-dimensional (2D) BM-MSC cultures under chondrogenic conditions were made from cross-linked PEG-fibrinogen (PF) and compared to thrombin-activated fibrin. Cell morphology, protein expression, DNA and sulfated proteoglycan (GAG) content were correlated to substrate properties such as stiffness and adhesiveness. Cell aggregation and chondrogenic markers, including collagen II and aggrecan, were observed on all PF substrates but not on fibrin. Shielding fibrinogen’s adhesion domains and increasing stiffness of the material are likely contributing factors that cause the BM-MSCs to display a more chondrogenic phenotype. One composition of PF corresponding to GelrinC™—a product cleared in the EU for cartilage repair—was found to be optimal for supporting chondrogenic differentiation of BM-MSC while minimizing hypertrophy (collagen X). These findings suggest that semi-synthetic biomaterials based on ECM proteins can be designed to favourably affect BM-MSC towards repair processes involving chondrogenesis.

## Linked entities

- **Proteins:** FGB (fibrinogen beta chain), acan.L (aggrecan L homeolog)
- **Chemicals:** polyethylene glycol (PubChem CID 9033), PEG (PubChem CID 174)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, TGFB3 (transforming growth factor beta 3) [NCBI Gene 7043] {aka ARVD, ARVD1, LDS5, RNHF, TGF-beta3}, ACAN (aggrecan) [NCBI Gene 176] {aka AGC1, AGCAN, CSPG1, CSPGCP, MSK16, SEDK}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** cartilage (MESH:D002357), hypertrophy (MESH:D006984), Fibrin clots (MESH:D013927), chondrogenesis (MESH:C536017), PF (MESH:C536414)
- **Chemicals:** FITC (MESH:D016650), hyaluronic acid (MESH:D006820), TCEP (MESH:C080938), Alamar Blue (MESH:C005843), phalloidin (MESH:D010590), tyramine (MESH:D014439), sodium acetate (MESH:D019346), TRITC (MESH:C009434), DAPI (MESH:C007293), PEG-diacrylate (MESH:C437167), proline (MESH:D011392), urea (MESH:D014508), sulfated glycosaminoglycan (MESH:C013786), ethidium homodimer-1 (MESH:C018533), calcein (MESH:C007740), CML (MESH:C048496), EDTA (MESH:D004492), dexamethasone (MESH:D003907), rhodamine (MESH:D012235), DMMB (MESH:C435946), GAG (MESH:D006025), Irgacure 2959 (MESH:C499598), chondroitin sulfate C (MESH:D002809), CO2 (MESH:D002245), pyruvate (MESH:D019289), calcein acetoxymethyl ester (MESH:C085925), sodium phosphate (MESH:C018279), linoleic acid (MESH:D019787), ascorbate-2-phosphate (MESH:C011669), alginate (MESH:D000464), glycine (MESH:D005998), ethidium (MESH:D004996), NaCl (MESH:D012965), AbDSerotec (-), formaldehyde (MESH:D005557), nitrogen (MESH:D009584), selenious acid (MESH:D020887), TRITC-phalloidin (MESH:C041085), L-cysteine (MESH:D003545), TritonX-100 (MESH:D017830), acetone (MESH:D000096), PEG (MESH:D011092), polystyrene (MESH:D011137),  (MESH:D005340),  (MESH:D015415),  (MESH:D020100)
- **Species:** Carica papaya (mamon, species) [taxon 3649], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** R&amp;D — Homo sapiens (Human), Embryonal rhabdomyosarcoma, Cancer cell line (CVCL_1649)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4585928/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4585928/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC4585928/full.md

---
Source: https://tomesphere.com/paper/PMC4585928